Skip to Content
Morningstar

HCA Healthcare Inc HCA

Morningstar Rating
Unlock
Stock XNYS Rating as of
$306.69 −7.43 (2.37%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

HCA Earnings: Strong Start to 2024, but Management Merely Maintains Guidance

Julie Utterback

Narrow-moat HCA Healthcare turned in better-than-anticipated first-quarter results that benefited from improving medical utilization trends. However, the company merely maintained its guidance for the full year, which appears to have disappointed the market. Considering that our expectations remain within current guidance ranges, we are not changing our $285 fair value estimate, and we continue to view HCA shares as about fairly valued.

Read Full Report

Price vs Fair Value

View History
HCA is trading at a 9% premium.
Price
$310.31
Fair Value
$897.00
Uncertainty
Medium
1-Star Price
$342.45
5-Star Price
$682.30
Economic Moat
Gbsdr
Capital Allocation
Pltcqzbjw

Bulls Say, Bears Say

Bulls

Beyond administrative function efficiency, HCA's large scale gives it an opportunity to test and expand best practices throughout its network of facilities to improve service quality and efficiency.

Bears

Healthcare policy changes will likely remain a key ESG risk until universal, affordable coverage is achieved in the U.S.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HCA is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$314.12
Day Range
$295.79–307.27
52-Week Range
$215.96–335.83
Bid/Ask
$300.37 / $313.99
Market Cap
$81.12 Bil
Volume/Avg
2.3 Mil / 1.0 Mil

Key Statistics

Price/Earnings (Normalized)
16.12
Price/Sales
1.26
Dividend Yield (Trailing)
0.80%
Dividend Yield (Forward)
0.86%
Total Yield
5.91%

Company Profile

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2022, the firm owned and operated 182 hospitals, 126 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Large Value
Total Number of Employees
310,000
Website
https://www.hcahealthcare.com

Competitors

Valuation

View More
Metric
HCA
DVA
THC
Price/Earnings (Normalized)
 16.1215.9313.77
Price/Book Value
 —11.235.98
Price/Sales
 1.261.020.49
Price/Cash Flow
 8.346.674.37
Price/Earnings
HCA
DVA
THC

Financial Strength

Metric
HCA
DVA
THC
Quick Ratio
 0.861.061.10
Current Ratio
 1.181.191.51
Interest Coverage
 4.983.952.79
Quick Ratio
HCA
DVA
THC

Profitability

Metric
HCA
DVA
THC
Return on Assets (Normalized)
 9.75%6.40%5.45%
Return on Equity (Normalized)
 —112.35%110.21%
Return on Invested Capital (Normalized)
 16.43%10.05%11.10%
Return on Assets
HCA
DVA
THC
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Care Facilities Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
FSNUY
Fresenius SE & Co KGaA ADR—Gctkzw$16.4 Bil
FSNUF
Fresenius SE & Co KGaA—Bzskn$16.4 Bil
BDUUY
Bangkok Dusit Medical Services PCL ADR—Vbrz$12.3 Bil
FMCQF
Fresenius Medical Care AG—Twzwc$11.9 Bil
FMS
Fresenius Medical Care AG ADRCmybvVmvvnn$11.9 Bil
DVA
DaVita IncPzkhfnhjTxwncy$11.7 Bil
UHS
Universal Health Services Inc Class B—Lkhqgvk$11.2 Bil
THC
Tenet Healthcare CorpKrrfmtjtHsd$9.5 Bil
AMN
AMN Healthcare Services IncBcmxmfqklGvjzpl$2.2 Bil

Sponsor Center